ALNYLAM PHARMACEUTICALS, INC. - FORM 10-K - EX-21.1 - EX-21.1 SUBSIDIARIES OF THE REGISTRANT - February 26, 2010

Attached files

file	filename
10-K - ALNYLAM PHARMACEUTICALS, INC. - ALNYLAM PHARMACEUTICALS, INC.	b78674e10vk.htm
EX-23.2 - EX-23.2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS OF REGULUS THERAPEUTICS INC. - ALNYLAM PHARMACEUTICALS, INC.	b78674exv23w2.htm
EX-31.2 - EX-31.2 SECTION 302 CERTIFICATION OF THE VICE PRESIDENT OF FINANCE AND TREASURER - ALNYLAM PHARMACEUTICALS, INC.	b78674exv31w2.htm
EX-99.1 - EX-99.1 REGULUS THERAPEUTICS INC.'S FINANCIAL STATEMENTS - ALNYLAM PHARMACEUTICALS, INC.	b78674exv99w1.htm
EX-32.2 - EX-32.2 SECTION 906 CERTIFICATION OF THE VICE PRESIDENT OF FINANCE AND TREASURER - ALNYLAM PHARMACEUTICALS, INC.	b78674exv32w2.htm
EX-23.1 - EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP - ALNYLAM PHARMACEUTICALS, INC.	b78674exv23w1.htm
EX-31.1 - EX-31.1 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - ALNYLAM PHARMACEUTICALS, INC.	b78674exv31w1.htm
EX-32.1 - EX-32.1 SECTION 906 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - ALNYLAM PHARMACEUTICALS, INC.	b78674exv32w1.htm
EX-10.16 - EX-10.16 2010 ANNUAL INCENTIVE PROGRAM - ALNYLAM PHARMACEUTICALS, INC.	b78674exv10w16.htm
EX-10.39 - EX-10.39 COLLABORATION AGREEMENT ENTERED INTO AS OF OCTOBER 29, 2009 - ALNYLAM PHARMACEUTICALS, INC.	b78674exv10w39.htm
EX-10.40 - EX-10.40 FIRST AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT ENTERED INTO AS OF NOVEMBER 2, 2009 - ALNYLAM PHARMACEUTICALS, INC.	b78674exv10w40.htm
EX-10.9 - EX-10.9 FORMS OF INCENTIVE STOCK OPTION AGREEMENT AND NONSTATUTORY STOCK OPTION AGREEMENT - ALNYLAM PHARMACEUTICALS, INC.	b78674exv10w9.htm

EXHIBIT 21.1

SUBSIDIARIES OF THE REGISTRANT


Name	Ownership Percentage	Jurisdiction of Organization
Alnylam U.S., Inc.	100 %	Delaware

Alnylam Europe AG	100 %	Germany

Alnylam Securities Corporation	100 %	Massachusetts

Regulus Therapeutics Inc.	49 %	Delaware